SHC4 and breast carcinoma: SHC4 and PAK5 have both been studied in breast cancer, with the former being used as one of 12 gene signatures linking molecular mechanisms to disease prognosis [37], and the latter being associated with invasion, metastasis, and poor outcome in several cancers [38–40].